Blog
Glow vs Klow Peptide Blend: Which to Choose?
What are Glow and Klow?
Glow and Klow are freeze-dried research blends built on the same three peptides: 50mg of GHK-Cu, 10mg of BPC-157 and 10mg of TB-500 in every vial. All three are studied for building and repair: GHK-Cu, a copper-binding tripeptide, in skin and collagen remodelling; BPC-157, a 15-amino-acid sequence from a gastric protein, in tendon, ligament and gut healing; TB-500, a synthetic peptide built on the actin-binding region of thymosin beta-4, in cell migration and wound closure.
Both powders are blue from the copper in GHK-Cu, and once mixed the two look the same in the vial. Klow carries one peptide more than Glow, and choosing between them comes down to whether the research needs it.
Simms Research sells both, the Glow Peptide Blend and the Klow Peptide Blend. The sections below cover what separates them, what the extra peptide does and costs, which blend fits which research, and how to move between them.
What is the difference between Glow and Klow?
KPV. Klow adds 10mg of it to Glow’s three peptides, which takes the vial from 70mg to 80mg and the price from $96 to $122. The two vials side by side:
| Glow | Klow | |
|---|---|---|
| Peptides | 3: GHK-Cu, BPC-157, TB-500 | 4: GHK-Cu, BPC-157, TB-500, KPV |
| Vial total | 70mg | 80mg |
| GHK-Cu | 50mg | 50mg |
| BPC-157 | 10mg | 10mg |
| TB-500 | 10mg | 10mg |
| KPV | None | 10mg |
| Ratio | 5 : 1 : 1 | 5 : 1 : 1 : 1 |
| Look | Blue powder, clear blue once mixed | Blue powder, clear blue once mixed |
| Price | $96 | $122 |
| Latest batch | GL281, 99.28% purity | 2026-KW189, 99.647% purity |
| Mixed vial keeps | 28 days at 2–8°C | 28 days at 2–8°C |
Everything Glow delivers, Klow delivers in the same amount. A dose holding 2mg of GHK-Cu holds 400mcg each of BPC-157 and TB-500 in either vial, mixed with the same water and drawn to the same unit mark. Storage, how long a mixed vial lasts and the brief sting GHK-Cu can cause match as well. Klow takes nothing away. It adds 400mcg of KPV to that dose, so the choice between the two blends is a choice about KPV.
Does Klow have KPV, and what does it do?
Yes, 10mg per vial, and it works on something the other three don’t. KPV is lysine-proline-valine, the last three amino acids of alpha-melanocyte-stimulating hormone (alpha-MSH). The full hormone is 13 amino acids long, SYSMEHFRWGKPV, and does two jobs: it calms inflammation, and it darkens skin through the melanocortin-1 receptor. The part that switches on pigment, His-Phe-Arg-Trp, sits at positions 6 to 9. KPV is positions 11 to 13, and keeps the hormone’s anti-inflammatory effect without its pigmentary action.
Its mechanism is its own. A 2008 Gastroenterology study found KPV is carried into gut and immune cells by PepT1, a transporter for small peptides that the colon switches on during inflammation. Inside, nanomolar amounts blocked NF-κB and MAP kinase signalling, two of the main switches for inflammatory cytokines. In mice without a working melanocortin-1 receptor, KPV still protected against colitis, so it doesn’t depend on the receptor behind tanning.
That is what Klow brings that Glow doesn’t. The other three peptides are studied mainly for building tissue back: collagen, blood vessels, tendon and migrating repair cells. KPV is studied mainly for turning the inflammatory signal down and for infection.
Glow vs Klow benefits: what the KPV research shows
Klow’s extra benefit sits in inflamed, infected and barrier tissue. The KPV record is in cells, mice and rabbits.
In human gut and immune cells, and in mice with DSS and TNBS colitis given KPV in their drinking water, it blocked NF-κB and MAP kinase signalling at nanomolar amounts, cut inflammatory cytokines and reduced colitis in both models (Dalmasso et al., Gastroenterology, 2008). In mice with DSS colitis and T-cell transfer colitis, recovery was faster, body weight came back and fewer inflammatory cells reached the colon, and every treated mouse without a working MC1R receptor survived DSS colitis (Kannengiesser et al., Inflammatory Bowel Diseases, 2008).
In rabbits with the corneal surface scraped away, every cornea treated with KPV eye drops for four days had fully resurfaced by 60 hours, and none of the placebo corneas had (Bonfiglio et al., Experimental Eye Research, 2006). In cultures it inhibited Staphylococcus aureus colony formation and reduced Candida albicans viability and germ-tube formation, down to picomolar amounts (Cutuli et al., Journal of Leukocyte Biology, 2000). In mice after a traumatic brain injury, one 1mg/kg injection left smaller brain lesions and less microglial activation (Schaible et al., PLoS One, 2013).
Read together, the studies put KPV’s value in three places: inflamed gut and barrier tissue; surfaces healing under inflammation or infection, from a scraped cornea to chemotherapy-damaged mouth lining in a later hydrogel study; and inflammation that spreads after an injury. The gut studies mostly gave KPV by mouth, where the inflamed colon takes it up through PepT1. The brain-injury study showed a single injection working far from the gut.
Two limits matter for the choice. No human trial of KPV is registered, and neither blend has been tested as a whole. And no published KPV study has looked at hair, while its skin work is about inflammation and wound surfaces rather than collagen. On those endpoints the research belongs to GHK-Cu, which both blends carry at 50mg.
Is there enough KPV in Klow to matter?
Yes. On its own, KPV is run at 200 to 500mcg a day in research protocols, and a standard Klow dose delivers 200 to 400mcg of it, a full KPV amount rather than a trace.
Klow holds GHK-Cu and each partner in a fixed 5 : 1 ratio, so GHK-Cu sets the dose and the rest follow. Its research range is 1 to 2mg daily (the GHK-Cu dosage guide covers where that range comes from), and each milligram of it brings 0.2mg each of BPC-157, TB-500 and, in Klow, KPV: 200mcg of each at 1mg of GHK-Cu a day, 300mcg at 1.5mg and 400mcg at 2mg. Over a week that is 1.4mg, 2.1mg and 2.8mg of each partner.
The vial holds what the label says: the current batch, 2026-KW189, measured 10.32mg of KPV, so 10 units from a 2.5mL mix carries 0.41mg.
The fixed ratio also sets KPV’s ceiling. Reaching the 500mcg top of KPV’s own range would take 2.5mg of GHK-Cu, above its 2mg research range, so Klow covers the lower and middle of KPV’s range. Research that needs KPV at the top of that range, or dosed apart from the GHK-Cu, needs it in a separate vial.
Glow vs Klow cost per day and per month
Klow costs $26 more per vial, $122 against $96 for Glow, and that $26 is the whole price of the 10mg of KPV.
At 2mg of GHK-Cu a day, either vial runs 25 days on its label amount. That is $3.84 a day for Glow and $4.88 for Klow, so choosing Klow costs $1.04 a day, or $7.28 a week, for 400mcg of KPV a day.
A mixed vial keeps 28 days in the refrigerator, and a 2mg daily dose is what empties a vial inside that window. Below about 1.8mg a day the 28 days run out first, so at lower doses the cost is one vial per four weeks: $96 or $122, and Klow comes to $26 more a month.
Is Glow or Klow better for skin and hair?
Glow, for most skin research and for hair. When the work is about building and remodelling tissue and inflammation isn’t measured (collagen density, photoaged skin, hair, tendon and ligament repair, clean wound closure), Klow’s KPV is a fourth active peptide that nothing reads, which also makes it harder to say which peptide drove a result. Glow keeps the design to three peptides and costs $26 less per vial.
Hair is the clearest case. Both blends hold the same 50mg of GHK-Cu, the peptide studied in hair follicles, and KPV has no published hair research, so for hair Klow adds nothing measured. Skin moves toward Klow only when the skin itself is inflamed, irritated or infected.
Is Klow worth it?
Yes, when inflammation, infection or a damaged barrier is part of what the research measures. Three kinds of model fit that.
Gut and barrier models. Colitis and intestinal-permeability work is where KPV’s evidence is deepest: two mouse models of colitis, and a transporter the inflamed colon switches on to take it up. Klow adds that on top of BPC-157, the blend’s other gut-studied peptide.
Inflamed or infected skin and wound surfaces. KPV cut S. aureus and Candida growth in culture and sped the resurfacing of scraped corneas. Wounds under a bacterial or yeast challenge, irritated skin and mucosal injury all sit inside that record.
Inflammation as an endpoint. Models that read cytokines, NF-κB activity or inflammatory cell counts alongside repair get both from one dose. The repair peptides and KPV move together at a fixed ratio, so every draw carries the same mix.
Glow vs Klow vs GHK-Cu and Wolverine
When the research centres on one part of the blend, a simpler vial fits better than either Glow or Klow. The Wolverine Peptide Stack holds 10mg each of BPC-157 and TB-500 for $79 and is dosed by those two directly. A plain GHK-Cu vial holds 50mg or 100mg, for $48 or $76. Glow, at $96, and Klow, at $122, are both dosed by their 50mg of GHK-Cu.
Where GHK-Cu alone is the subject, as in most skin and hair work, the plain GHK-Cu vial holds the same 50mg as either blend. Where BPC-157 and TB-500 are the subject, the Wolverine Peptide Stack lets them set the dose directly. A Wolverine vial with 2mL of water holds 5mg per mL of each, so 500mcg of each is 10 units, while the same 500mcg of BPC-157 from Glow or Klow would bring 2.5mg of GHK-Cu with it.
Adding KPV to Glow instead of choosing Klow
A separate KPV vial next to Glow works, and it trades simplicity for control. The second vial needs its own water, its own draw and its own 28-day clock once mixed, but KPV can then run on its own schedule, up to the top of its 200–500mcg range, and start or stop without touching the Glow. Klow keeps KPV in the same draw at one part to five of GHK-Cu, so every dose carries the same mix from one vial. For a steady share of KPV throughout, Klow is the simpler design; for KPV varied on its own, the separate vial is.
Glow or Klow: which to choose
Choose Klow for research where inflammation, infection or a damaged barrier is part of the model. $26 a vial buys 10mg of a peptide with a mechanism none of the other three share, delivered at 200 to 400mcg a day, inside KPV’s own working range, from the same draw, with nothing else in the blend reduced.
Choose Glow for skin, collagen, hair and clean repair work. The peptide behind those results, GHK-Cu, is the same 50mg in both vials, and Glow delivers it with one fewer variable for $26 less.
Where one peptide is the whole subject, plain GHK-Cu or the Wolverine Peptide Stack fits better than either blend.
Switching between Glow and Klow: water and units
Mix both vials by their GHK-Cu, not by the vial total, and nothing about the draw changes when moving from one blend to the other. With the same water in each, the GHK-Cu, BPC-157 and TB-500 per unit match, and the Klow dose simply carries KPV as well. Units are on a U-100 insulin syringe, where 100 units make 1mL. With 2.5mL of water both blends hold 20mg of GHK-Cu per mL, so 1mg is 5 units and 2mg is 10; with 5mL they hold 10mg per mL, and the same doses are 10 and 20 units. Total peptide per mL is 28mg in Glow and 32mg in Klow at 2.5mL, and 14mg and 16mg at 5mL.
Mixing each vial to the same total strength does the opposite. 3.5mL in Glow and 4mL in Klow both give 20mg per mL of total peptide, but the same 10 units then holds 1.43mg of GHK-Cu from the Glow vial and 1.25mg from the Klow vial, 12.5% less, with the BPC-157 and TB-500 cut by the same share.

The 5mL mix doubles every unit count and spreads each dose through twice the liquid, which also eases the GHK-Cu sting (why it stings, and the fix). The Simms Research peptide calculator works out any other volume. Add the water slowly along the glass, swirl rather than shake, and store the mixed vial cold, 2–8°C (36–46°F). Bacteriostatic water comes in 10mL vials from Simms Research.
What each batch measured
Close to the label in every batch, KPV included. Simms Research’s certificates list each peptide in a blend separately, so the KPV and the shared base can both be checked batch by batch:
| Batch and test date | GHK-Cu, 50mg label | BPC-157, 10mg | TB-500, 10mg | KPV, 10mg |
|---|---|---|---|---|
| Klow 2026-KW189, Jul 17, 2026 | 55.84mg | 11.17mg | 10.82mg | 10.32mg |
| Klow KW126, May 19, 2026 | 49.61mg | 10.12mg | 9.79mg | 11.09mg |
| Glow GL281, Apr 14, 2026 | 55.14mg | 12.32mg | 11.59mg | None |
| Glow GL133, Feb 13, 2026 | 54.12mg | 13.94mg | 11.18mg | None |
Both Klow batches measured more KPV than the 10mg on the label, 10.32mg and 11.09mg, and the shared base in the Glow and Klow batches lines up within a few milligrams. Twelve of the fourteen measurements came in above the label, and the two below it were within 2.1%. On the current batches, 10 units drawn from a 2.5mL mix comes to about 2.2mg of GHK-Cu rather than 2mg, 2.21mg from Glow GL281 and 2.23mg from Klow 2026-KW189, so a 2mg GHK-Cu dose on either is closer to 9 units.

Klow’s latest batch, 2026-KW189, went through the fuller panel: purity and content measured on three separate vials, identity confirmed by LC-MS, and clean endotoxin, heavy-metal and sterility screens. Glow’s latest, GL281, was measured for purity by HPLC-UV and for the content of each peptide, with identity confirmed by LC-MS and a clean endotoxin screen. The certificates sit on the Glow and Klow lab results pages, with a line-by-line walkthrough in How to Read a Peptide Certificate of Analysis.
Frequently asked questions
Is Klow stronger than Glow?
Not in the shared peptides: the GHK-Cu, BPC-157 and TB-500 are identical in both. Klow is broader rather than stronger, with a fourth peptide that works on inflammation.
Can you use Glow and Klow together?
There is no reason to. Klow already holds everything in Glow at the same amounts, so running both would double the GHK-Cu, BPC-157 and TB-500 in each day’s dose and push the GHK-Cu past its 1–2mg range.
Does Klow make you tan?
No. Tanning comes from the His-Phe-Arg-Trp core in the middle of alpha-MSH, the part the Melanotan peptides are built around. KPV is the hormone’s last three amino acids and does not contain it.
Does Glow make you lose weight?
No. None of its three peptides is studied for fat loss; they are repair and remodelling peptides.
Do Glow and Klow sting?
The brief sting some researchers notice comes from GHK-Cu, and both blends hold the same amount. Mixing with 5mL of water instead of 2.5mL halves the strength and eases it.
Are Glow and Klow approved?
No. Simms Research sells both for laboratory research use only.